Literature DB >> 30159665

Sleep Quality in Ulcerative Colitis: Associations with Inflammation, Psychological Distress, and Quality of Life.

Megan M Hood1, Rebecca Wilson2, Annika Gorenz2, Sharon Jedel2, Shohreh Raeisi2, Stevan Hobfoll2, Ali Keshavarzian2.   

Abstract

PURPOSE: Treatment of ulcerative colitis (UC), given its chronicity and its associated disruptive and often distressing symptoms, is increasingly focusing on maximizing patient quality of life. Poorer quality of life has been found among patients with poor sleep quality, which is much more common in patients with UC than in the general population and may be associated with inflammation and psychological distress.
METHOD: Forty-seven patients with UC (n = 11 flaring) completed measures of sleep quality, depression, state anxiety, gastrointestinal-related anxiety, perceived stress, and quality of life. Measures of inflammation were also obtained.
RESULTS: Patients endorsed high rates of poor sleep quality, which was highly correlated with depression and poorer inflammatory bowel disease-related quality of life, but was generally not related to other areas of psychological functioning or inflammation. Sleep quality was significantly independently associated with depression and female gender.
CONCLUSION: Poor sleep quality is prevalent in patients with UC and is strongly related to depression, suggesting that sleep and mood are important areas to assess in patients with UC in order to inform tailored treatment to improve quality of life.

Entities:  

Keywords:  Depression; Distressing symptoms; Inflammatory bowel disease; Quality of life; Sleep quality; Ulcerative colitis

Mesh:

Year:  2018        PMID: 30159665     DOI: 10.1007/s12529-018-9745-9

Source DB:  PubMed          Journal:  Int J Behav Med        ISSN: 1070-5503


  33 in total

1.  Sleep disorders and inflammatory disease activity: chicken or the egg?

Authors:  Parth J Parekh; Edward C Oldfield Iv; Vaishnavi Challapallisri; J Catsby Ware; David A Johnson
Journal:  Am J Gastroenterol       Date:  2014-08-26       Impact factor: 10.864

2.  Self-reported sleep quality and quality of life for individuals with chronic pain conditions.

Authors:  L A Menefee; E D Frank; K Doghramji; K Picarello; J J Park; S Jalali; L Perez-Schwartz
Journal:  Clin J Pain       Date:  2000-12       Impact factor: 3.442

3.  Impaired sleep quality in Crohn's disease depends on disease activity.

Authors:  Rachel Gingold-Belfer; Nir Peled; Sigal Levy; Neriel Katz; Yaron Niv; Ronnie Fass; Gerald Fraser; Ram Dickman
Journal:  Dig Dis Sci       Date:  2013-10-11       Impact factor: 3.199

4.  Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis.

Authors:  J Powell-Tuck; D W Day; N A Buckell; J Wadsworth; J E Lennard-Jones
Journal:  Dig Dis Sci       Date:  1982-06       Impact factor: 3.199

Review 5.  The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease.

Authors:  James D Lewis
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

Review 6.  The relevance of sleep abnormalities to chronic inflammatory conditions.

Authors:  Z Ranjbaran; L Keefer; E Stepanski; A Farhadi; A Keshavarzian
Journal:  Inflamm Res       Date:  2007-02       Impact factor: 4.575

7.  Gender difference on the symptoms, health-seeking behaviour, social impact and sleep quality in irritable bowel syndrome: a Rome II-based survey in an apparent healthy adult Chinese population in Taiwan.

Authors:  C-L Lu; F-Y Chang; H-C Lang; C-Y Chen; J-C Luo; S-D Lee
Journal:  Aliment Pharmacol Ther       Date:  2005-06-15       Impact factor: 8.171

8.  Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status.

Authors:  G Addolorato; E Capristo; G F Stefanini; G Gasbarrini
Journal:  Scand J Gastroenterol       Date:  1997-10       Impact factor: 2.423

Review 9.  Laboratory markers in IBD: useful, magic, or unnecessary toys?

Authors:  S Vermeire; G Van Assche; P Rutgeerts
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

10.  Development of the Perceived Stress Questionnaire: a new tool for psychosomatic research.

Authors:  S Levenstein; C Prantera; V Varvo; M L Scribano; E Berto; C Luzi; A Andreoli
Journal:  J Psychosom Res       Date:  1993-01       Impact factor: 3.006

View more
  7 in total

Review 1.  Sleep Disturbances in the Elderly Patient with Inflammatory Bowel Disease.

Authors:  Taha Qazi; Francis A Farraye
Journal:  Curr Treat Options Gastroenterol       Date:  2019-12

Review 2.  Sleep and Fatigue in IBD: an Unrecognized but Important Extra-intestinal Manifestation.

Authors:  Andrew Canakis; Taha Qazi
Journal:  Curr Gastroenterol Rep       Date:  2020-01-30

3.  Sphk1 promotes ulcerative colitis via activating JAK2/STAT3 signaling pathway.

Authors:  Jiawen Liu; Bo Jiang
Journal:  Hum Cell       Date:  2019-10-12       Impact factor: 4.174

Review 4.  Sleep Deficiency: A Symptoms Perspective: Exemplars from Chronic Heart Failure, Inflammatory Bowel Disease, and Breast Cancer.

Authors:  Nancy S Redeker; Samantha Conley; Youri Hwang
Journal:  Clin Chest Med       Date:  2022-06       Impact factor: 4.967

5.  Unmet Medical Needs in the Management of Ulcerative Colitis: Results of an Italian Delphi Consensus.

Authors:  Marco Daperno; Alessandro Armuzzi; Silvio Danese; Walter Fries; Giuseppina Liguori; Ambrogio Orlando; Claudio Papi; Mariabeatrice Principi; Fernando Rizzello; Angelo Viscido; Paolo Gionchetti
Journal:  Gastroenterol Res Pract       Date:  2019-09-02       Impact factor: 2.260

6.  Mediation Effect of the Coping Strategies on the Relation Between Stress and Sleep Quality.

Authors:  Sung Min Kim; Yoo Hyun Um; Tae Won Kim; Ho-Jun Seo; Jong-Hyun Jeong; Seung-Chul Hong
Journal:  Psychiatry Investig       Date:  2022-07-21       Impact factor: 3.202

Review 7.  Interrogating the Gut-Brain Axis in the Context of Inflammatory Bowel Disease: A Translational Approach.

Authors:  Stephen M Collins
Journal:  Inflamm Bowel Dis       Date:  2020-03-04       Impact factor: 5.325

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.